Bridge to Breakthrough Award
Ranmal Samarasinghe, MD, PhD / University of California, Los Angeles
With this grant, the team will test if correcting a gene can bring memory supporting cells back online.
Bridge to Breakthrough Award
Ankit Khambhati, PhD / University of California, San Francisco
By using advanced MRI technology, this team can look deeper into the brain’s unique wiring and structure than ever before.
Bridge to Breakthrough Award
Lauren Lau, PhD / Massachusetts General Hospital
Ultimately, this work aims to identify the biological mechanisms that trigger seizures and guide the development of more targeted and effective therapies to improve seizure control and quality of life for people living with epilepsy.
Bridge to Breakthrough Award
James Niemeyer, PhD / Cornell University
By studying both acute seizures and Dravet syndrome, Dr. Niemeyer hopes to uncover new cellular and network targets for therapies.
Catalyst Award
Deborah Kurrasch, PhD / Stream Neuroscience
The goal of this research is to complete safety testing to confirm that SN‑2000 is well‑tolerated and to determine safe dosing levels for its future development as a treatment for people with epilepsy.
SUDEP Clinical Biomarker Team Science Award
Satya Sahoo, PhD / Case Western Reserve University
Using advanced artificial intelligence, this team aims to make advances that will facilitate the development of a personalized risk prediction tool that can estimate an individual’s SUDEP risk and clearly explain the reasons behind it.
SUDEP Clinical Biomarker Team Science Award
Andrew Landstrom, MD, PhD / Children's Hospital of Philadelphia
This project will identify which children are at highest risk and which medications are safest, with the goal of preventing sudden death and providing families and guiding clinical care of patients.
SUDEP Clinical Biomarker Team Science Award
Shobi Sivathamboo, PhD / Monash University
By analyzing patterns in heart rhythm, breathing, brain activity, arousal, and sleep, this project aims to uncover measurable warning signs of risk to inform prevention strategies.
Rare Epilepsy Partnership Award
Geoffrey Swanson, PhD / Northwestern University
Dr. Swanson’s team will test whether reducing the activity of the overactive kainate receptor, using a gene therapy approach, can improve seizures and other behaviors in a new mouse model that carries the same genetic change found in people.
